JONATHAN MICHAEL YINGLING Insider Trading
Get free email notifications about insider trading for JONATHAN MICHAEL YINGLING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JONATHAN MICHAEL YINGLING. JONATHAN MICHAEL YINGLING is a Chief Scientific Officer in IDERA PHARMACEUTICALS, INC. ($IDRA) and a SVP of Early Development in IDERA PHARMACEUTICALS, INC. ($IDRA) and a SVP, Early Development in IDERA PHARMACEUTICALS, INC. ($IDRA) and a Chief Scientific Officer in BIND Therapeutics, Inc ($BIND).
Address: C/O BIND THERAPEUTICS, INC. 325 VASSAR STREET CAMBRIDGE 02139 MA
Companies in which JONATHAN MICHAEL YINGLING is an Insider
DNIB UNWIND, INC.
Trading Symbol: BINDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JONATHAN MICHAEL YINGLING: Chief Scientific Officer
Holdings: 0 shares
Latest Transaction: Dec 16 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JONATHAN MICHAEL YINGLING: Chief Scientific Officer, SVP, Early Development, SVP of Early Development
Holdings: 36,358 shares
Current Value: $56,718
Latest Transaction: Jan 14 2020
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JONATHAN MICHAEL YINGLING
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 1.79 | 50,000 | 89,500 | 50,000 | |
Jan 14 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Grant | A | 0.00 | 20,000 | 0 | 36,358 | 16.4 K to 36.4 K (+122.26 %) |
Jan 10 2020 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Sell | S | 1.78 | 1,742 | 3,101 | 16,358 | 18.1 K to 16.4 K (-9.62 %) |
Jul 11 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 2.52 | 45,500 | 114,660 | 45,500 | |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 3.14 | 45,500 | 142,870 | 45,500 | |
Jan 07 2019 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Grant | A | 0.00 | 18,100 | 0 | 18,100 | 0 to 18.1 K |
Aug 15 2018 | IDRA | IDERA PHARMACEUTIC ... | YINGLING JONATHAN MICHAEL | Chief Scientific Of ... | Option Exercise | A | 7.39 | 32,500 | 240,175 | 32,500 |